Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 4Sanofi
02 2Polfa Tarchomin
03 2Adcock Ingram
04 1Alter Laboratories Sa
05 1Aristo Pharma GmbH
06 1BASI
07 2Bharat Parenterals Limited
08 2BioMatrix Healthcare
09 1Cifarma
10 1Cinfa
11 2DANHSON
12 2Flagship Biotech International Pvt. Ltd
13 6GL Pharma
14 1Grindeks AS
15 1Harson Laboratories
16 2KIVIPharm
17 1Kalcex
18 1Kwality Pharmaceuticals
19 2LABORATORIOS NORMON SA
20 1Laboratorios ERN
21 2Mars Therapeutics
22 1Maxheal Pharmaceuticals (India) Ltd
23 1Mepha Pharma
24 1Mepro Pharmaceuticals
25 2Montage Laboratories
26 1MosFarma
27 1Neogen N.V.
28 4Opel Healthcare Switzerland Ag
29 1Opella Healthcare Group
30 3Opella Healthcare South Africa (Pty) Ltd
31 2Pannon
32 1Polifarma
33 1Reyoung pharmaceutical
34 1SINTETICA SA
35 2Spirig Healthcare
36 4Streuli Pharma
37 1Umedica Laboratories
38 1Vecol
39 2Zentiva
40 1Zuma Pharma
01 1Capsule
02 1Coated Tablet
03 2DC Granules
04 1Film Coated Tablet
05 1Hard Capsule
06 1INJ
07 2INJECTION
08 7Injectable Solution
09 10Injection
10 1Injection Solution
11 2Liquid Injection
12 1Oral Drop
13 2Oral Drop In Solution
14 2Oral Drops
15 3Oral Solution
16 1Solution For Injection
17 3Solution for Injection
18 1Sterile Solution
19 1Suppository
20 4TAB
21 1TABLET
22 18Tablet
23 3Blank
01 12Allowed
02 8Authorized
03 2Cancelled
04 5Dossier Availability- Q2 2017
05 1Dossier Availability- Q4 2016
06 2Dossier Availability: Q3 2024
07 6Generic
08 1Generic eCTD
09 3Originator
10 29Blank
01 1Analgin
02 1Buscapina Compositum
03 2Buscopan compositum 10 mg/250 mg
04 1Buscopan compositum 20 mg/2.5 g
05 1Buscopresc Compositum
06 1Difebril
07 1Dipyrine
08 1Metalgold
09 1Metamizol Alter
10 1Metamizol Cinfa
11 1Metamizol Gobens
12 1Metamizol Kalceks
13 1Metamizol Normon
14 2Metamizol Spirig HC
15 1Metamizol-Mepha
16 1Metamizole Base
17 2Metamizole(Analgin)
18 4Minalgin
19 4Novalgin
20 3Novalgina
21 1Novaminsulfon Synthetic
22 1Omalgin
23 2Panalgorin
24 2Scopex Co
25 1Spasmopharm
26 1Turbet
27 1UNALGIN
28 29Blank
01 6Austria
02 1Brazil
03 2Bulgaria
04 1Canada
05 3China
06 1Colombia
07 2Czech Republic
08 2Hungary
09 15India
10 3Italy
11 2Poland
12 1Russia
13 5South Africa
14 10Spain
15 12Switzerland
16 1Turkey
17 1Uzbekistan
18 1Blank
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Novalgina
Dosage Form :
Dosage Strength : Gtt Os 20 Ml 500 Mg/Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Availability: Q3 2024
Registration Country : Poland
Brand Name :
Dosage Form : Solution for Injection
Dosage Strength : 1000MG/2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability: Q3 2024
Registration Country : Poland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Novalgina
Dosage Form :
Dosage Strength : To 5 Supp 1 G
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Novalgina
Dosage Form :
Dosage Strength : 5 Ampoules Im Ev 1 G 2 Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Cancelled
Registration Country : Spain
Metamizol Sodium; Butylscopolamine Bromide
Brand Name : Buscapina Compositum
Dosage Form : Coated Tablet
Dosage Strength : 250MG; 10 MG
Packaging :
Approval Date : 1959-06-01
Application Number : 32174
Regulatory Info : Cancelled
Registration Country : Spain
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Availability: Q3 2024
Registration Country : Poland
Brand Name :
Dosage Form : Solution for Injection
Dosage Strength : 2500MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability: Q3 2024
Registration Country : Poland
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength :
Packaging : 30ml & 100ml Multi dose vial
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : Dossier Availability- Q4 2016
Registration Country : Austria
Brand Name :
Dosage Form : Solution for Injection
Dosage Strength : 500MG/ML
Packaging : 2 Ml, 5 Ml, 10 Ml
Approval Date :
Application Number :
Regulatory Info : Dossier Availability- Q4 2016
Registration Country : Austria
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Brand Name :
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Brand Name :
Dosage Form : Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Brand Name :
Dosage Form : Tablet
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Brand Name :
Dosage Form : Tablet
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Brand Name :
Dosage Form : Tablet
Dosage Strength : 60MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Regulatory Info : Generic eCTD
Registration Country :
Brand Name :
Dosage Form : INJECTION
Dosage Strength : 500MG/2ML
Packaging : 5 ml amp
Approval Date :
Application Number :
Regulatory Info : Generic eCTD
Registration Country :
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 500mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 500MG
Packaging : 1 x 10 T
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : Generic
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Canada
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Tablet
Dosage Strength : 500mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Regulatory Info : Generic
Registration Country : India
Brand Name : UNALGIN
Dosage Form : INJECTION
Dosage Strength : 500MG/ML
Packaging : 2 / 5ml amp ; 30ml vial
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
